USPTO Grants Quick-Med Tenth U.S. Patent for NIMBUS(R) Technology
02 Janeiro 2013 - 11:00AM
Marketwired
GAINESVILLE, FL--(Marketwire -
January 02, 2013) - Quick-Med Technologies, Inc. (OTCQB:
QMDT), a life sciences company that is developing innovative
technologies for the healthcare and consumer markets, announced
today that it has been awarded a tenth U.S. patent for its novel,
non-leaching NIMBUS®
antimicrobial technology.
The U.S. Patent and Trademark Office has granted Quick-Med
Technologies U.S. Patent No. 8,343,523 titled, "Disinfectant with
Durable Activity Based on Alcohol-Soluble Quaternary Ammonium
Polymers and Copolymers." The new patent provides for a novel
alcohol-soluble, water insoluble disinfectant for achieving a
prolonged antimicrobial property to a variety of surfaces including
skin. It covers the composition and method for several NIMBUS
polyurethane quaternary applications including certain formulations
of the Company's proprietary NimbuDerm™ hand sanitizer and a
variety of NIMBUS applications including medical adhesives, foam
wound dressings, sutures, catheters and other medical
tubing.
"We are very pleased that the U.S. Patent Office has
granted this tenth NIMBUS patent which further solidifies our
leadership in non-leaching antimicrobial technology," said Bernd
Liesenfeld, Quick-Med's president. "This new patent captures
additional special characteristics of our unique NIMBUS technology
and provides intellectual property protection for several key
applications of our growing family of NIMBUS antimicrobial
polymers."
About NIMBUSQuick-Med's
patented technology, NIMBUS, is a cutting-edge antimicrobial
technology that has been custom designed for wound care and other
medical applications. NIMBUS received De Novo FDA clearance in 2009 and has
been commercialized in traditional wound care applications. It
is the only non-leaching antimicrobial dressing which, by design,
poses no risk of bacteria developing resistance. NIMBUS technology
is protected by twelve U.S. patents and patents pending and 24
foreign counterparts. Additional applications under development
include advanced wound dressings, medical adhesives, catheters, and
contact lenses.
About Quick-Med Technologies,
Inc.Quick-Med Technologies, Inc. is a life sciences company
that is developing proprietary, broad-based technologies for
infection prevention and control in the consumer and healthcare
markets. In addition to NIMBUS, Quick-Med's Stay Fresh® technology provides highly
durable antimicrobial protection for laundered apparel and other
textile applications and its NimbuDerm™ technology is being
developed as a long-lasting hand sanitizer. For more information,
see: www.quickmedtech.com.
© 2013 Quick-Med Technologies, Inc. All rights reserved.
NIMBUS® and Stay Fresh® are registered trademarks and
NimbuDerm™ is a trademark of Quick-Med Technologies, Inc.
Forward-looking statements
(statements which are not historical facts) in this release are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. For this purpose, any
statements contained in this release that are not statements of
historical fact may be deemed to be forward-looking statements.
Without limiting the generality of the foregoing, words such as
"may", "will", "to", "expect", "plan", "believe", "anticipate",
"intend", "could", "would", "estimate", and/or "continue" or the
negative or other variations thereof or comparable terminology are
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the
Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System
at www.sec.gov.
CONTACT: Quick-Med Technologies Bernd
LiesenfeldPresident (888) 835.2211 Ext
103 bliesenfeld@quickmedtech.com
Quick Med Technologies (CE) (USOTC:QMDT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Quick Med Technologies (CE) (USOTC:QMDT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024